Observational studyBMC cancer2022

Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study.

Akira Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.